1-2 of 2
Brenda W. Cooper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia

Brenda W. Cooper, Gareth J. Veal, Tomas Radivoyevitch, Michael J. Tilby, Howard J. Meyerson, Hillard M. Lazarus, Omer N. Koc, Richard J. Creger, Graham Pearson, Geoff M. Nowell, David Gosky, Stephen T. Ingalls, Charles L. Hoppel, Stanton L. Gerson
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6830–6839.
https://doi.org/10.1158/1078-0432.CCR-04-0097
Published: 22 October 2004
View article titled, A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia
Open the PDF for A Phase I and Pharmacodynamic Study of Fludarabine, Carboplatin, and Topotecan in Patients With Relapsed, Refractory, or High-Risk Acute Leukemia in another window
Journal Articles

Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies

Afshin Dowlati, Hillard M. Lazarus, Paul Hartman, James W. Jacobberger, Cecilia Whitacre, Stanton L. Gerson, Pamela Ksenich, Brenda W. Cooper, Phyllis S. Frisa, Megan Gottlieb, Anthony J. Murgo, Scot C. Remick
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5929–5935.
Published: 15 December 2003
View article titled, Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies
Open the PDF for Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies in another window